Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
KeyBanc has raised its 12-month price objective on EnPro Industries to $310 from $260 while maintaining an Overweight rating, reflecting confidence in ongoing earnings momentum following the company’s fourth-quarter 2025 results. Data noted in the coverage also suggests the shares may be trading above their Fair Value amid a 31.58% one-year gain.
KeyBanc increased its price target on Analog Devices (ADI) to $430 from $375 and kept an Overweight rating after the company reported better-than-expected first-quarter results and issued second-quarter guidance that outpaced seasonal norms. The upside was led by Communications - notably data center optical - and Consumer end markets, while Industr…
KeyBanc reduced its price target on Global-E Online Ltd to $40 from $45 while retaining an Overweight rating, citing current market conditions even as the company reported strong fourth-quarter performance, 38% year-over-year gross merchandise volume growth and 31.57% revenue growth over the last twelve months to $888.45 million. Other firms adjust…
Sintx Technologies director Mark Lewis Anderson bought 3,000 shares of the company's common stock on February 18, 2026, paying $3.02 per share for a total of $9,060. After the trade, Anderson holds 18,000 shares. Separately, the company announced the appointment of Ryan Elmore as president effective March 16, 2026, and Ascendiant Capital lowered it…
Jiuzi Holdings Inc (NASDAQ:JZXN) saw its stock rise 22.4% in premarket trading after disclosing talks to expand a recent private placement to as much as $100 million. The proposed expansion would follow a $60 million strategic financing completed on Feb. 13, 2026, and would be priced at no less than $2 per share. Proceeds are intended to bolster th…
KeyBanc reaffirmed an Overweight rating on Addus HomeCare (ADUS) with a $150 price target, noting room for upside from the current share price and expecting fourth-quarter results to be broadly in line with forecasts. The firm highlighted the possibility of a sizeable Personal Care acquisition in 2026, while Citizens reiterated a Market Outperform …
KeyBanc increased its DoorDash (DASH) price target to $280 from $275 while maintaining an Overweight rating, pointing to robust underlying Gross Order Volume trends in the fourth-quarter report and early profitability in newer verticals. The firm projects stronger GOV-driven growth through 2027 and set the new target at 25 times its 2027 EV/EBITDA …
KeyBanc increased its target price on Nordson Corp. to $335 from $295 and kept an Overweight rating after the company's fiscal first-quarter 2026 results, pointing to strong momentum in the ATS segment and evidence of order and backlog reinforcement. The firm flagged margin pressure in IPS but described Nordson's guidance as conservative. Other ana…
KeyBanc reduced its 12-month price objective for Snowflake Inc. to $235 from $285 but kept an Overweight rating, pointing to weaker peer multiples in the sector. A customer and partner survey showed improving spend intentions and broader product adoption, and Snowflake disclosed multiple strategic moves including an acquisition, an OpenAI partnersh…
KeyBanc increased its 12-month price target on Element Solutions (ESI) to $36 from $34 while keeping an Overweight rating, pointing to stronger electronics demand driven by adoption of advanced packaging and a widening market that now includes printed circuit boards. The firm noted margin pressure from a temporary spike in metal costs but raised ea…
Kinetik Holdings Inc saw its stock rise in premarket trading after reports that the company is assessing a possible sale following an approach from Western Midstream Partners. The company, valued at roughly $7.2 billion and operating thousands of miles of pipeline in the Delaware Basin, is said to be considering a process to attract interest from s…
Novo Nordisk (NVO) is trading near $48.47 after a steep re-rating driven by competitive share loss, welcome price pressure, and conservative 2026 guidance. At a market cap of $213.8B and a PE of 14.1, the stock looks materially cheaper than its 52-week peak. This trade idea advocates a tactical long: entry at $48.47, stop at $43.08, target $60.00 o…
Alphabet's scale in cloud, search, and multimodal AI gives it a clearer path to near-term monetization than Apple's device-first approach. Valuation, cash flow and technicals create an actionable long trade: enter near $300, stop at $281, target $350 over the next 45 trading days while watching cloud customer growth and Gemini monetization as catal…
The White House has prepared detailed operational plans that would rely on British facilities - Diego Garcia and RAF Fairford - for potential strikes on Iran. The UK has not given prior approval for use of those bases for such an operation, citing worries about compliance with international law. In response to the absence of clearance, President Tr…
Gencor (GENC) sits on a $57.4 million backlog and $147.7 million in cash and securities with no debt. That mix - an orderbook large relative to trailing annual sales and a net-cash balance sheet - supports a long trade into fiscal 2026 as order conversion resumes. Entry $15.14, stop $13.50, target $20.00, long-term (180 trading days).
A cluster of high-value insider trades was disclosed on Wednesday, February 18, 2026. Director-level purchases of First American Financial Corp and KKR & Co. led the buying activity, while substantial sales at Johnson & Johnson, Howmet Aerospace and other firms accounted for the day’s largest disposals. Several transactions were executed under pre-…
KeyBanc has reiterated an Overweight rating on Autodesk Inc. (ADSK) and set a $365.00 price target, implying roughly 59% upside from the current share price. The broker's quarter-end checks came in ahead of expectations and align with the company’s positive preannouncement, while company actions including a global restructuring and an early January…
BMO Capital Markets raised its price target on Booking Holdings to $6,200 from $6,000 and kept an Outperform rating after the company reported fourth-quarter 2025 results that beat Street expectations on bookings and adjusted EBITDA. While the top-line outlook for 2026 topped consensus, margins came in below Street expectations as management earmar…
Rosenblatt Securities reiterated a Buy rating and a $50.00 price target on Applied Optoelectronics (AAOI) ahead of the company's fiscal fourth-quarter earnings, forecasting continued revenue momentum driven by growing Amazon business and initial volume 800G transceiver shipments. The firm expects roughly $133 million in Q4 revenue and projects mean…
Fiverr drew multiple analyst downgrades following an earnings report and guidance that highlighted a more challenging transition to higher-value customers. While higher-ticket transactions are strengthening, revenue and EBITDA guidance for Q1 and 2026 missed consensus and prompted concerns about execution risk, subdued marketplace trends and near-t…
Andrew Mountbatten-Windsor was detained on his 66th birthday as police investigate whether he leaked government material to Jeffrey Epstein, in connection with alleged misconduct in a public office during his tenure as a UK trade envoy. The arrest compounds decades of controversies that have eroded his public standing, including a civil settlement …
Nu Skin (NUS) trades at depressed multiples despite positive free cash flow, a modest debt load, and returns on capital consistent with a healthy business. This trade idea lays out a long trade with defined entry, stop, and target using current valuation and technical context - the idea is to own the stock while management executes on customer acqu…
Guggenheim increased its price target on NewAmsterdam Pharma to $45 from $41 and kept a Buy rating after moving up its estimate for an EU launch of obicetrapib to 2027 from 2029. The firm cited faster regulatory timing and ongoing progress in the PREVAIL outcomes trial, while broader analyst sentiment remains bullish and regulatory milestones for 2…
Bernstein SocGen Group increased its price target on Analog Devices to $375 from $270 while maintaining a Market Perform rating. The firm raised its fiscal 2027 EPS estimate and applied a higher earnings multiple, even as other brokers pushed up targets after strong quarterly results and a dividend increase. Valuation concerns and recent strong sha…
Guggenheim reduced its 12-month price target on DoorDash Inc. to $255 from $275 while keeping a Buy recommendation. The firm pointed to stronger-than-expected marketplace order trends and raised top-line forecasts but trimmed the target to reflect multiple compression across the tech sector. Management reiterated its 2026 margin guidance and outlin…
